Mitsubishi Tanabe Pharma Europe Ltd.
GPTKB entity
Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
immunology
neurology rare diseases |
| gptkbp:headquartersLocation |
gptkb:London
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mitsubishi Tanabe Pharma Europe Ltd.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:parentCompany |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
|
| gptkbp:subsidiary |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
|
| gptkbp:bfsParent |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:bfsLayer |
6
|